Genentech to Present Data at ASH 2022 Showcasing Strength of Hematology Portfolio and Expanding Into New Areas to Address More Patient Needs

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that it will present new data from its industry-leading hematology portfolio at the 64th American Society of Hematology (ASH) Annual Meeting from December 10-13, 2022. The data to be presented span numerous...

Click to view original post